Emergent BioSolutions Newsroom

Emergent BioSolutions Analyst Ratings

BenzingaNov 7 10:04 ET

Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsNov 7 08:31 ET

Emergent BioSolutions Analyst Ratings

BenzingaSep 13 11:48 ET

Emergent Biosolutions Price Target Announced at $16.00/Share by Rodman & Renshaw

Dow JonesAug 22 13:38 ET

Emergent BioSolutions Analyst Ratings

BenzingaAug 22 13:28 ET

Rodman & Renshaw Upgrades Emergent BioSolutions(EBS.US) to Buy Rating, Cuts Target Price to $16

Moomoo NewsAug 22 07:33 ET

Emergent BioSolutions Analyst Ratings

BenzingaAug 16 09:44 ET

Emergent BioSolutions Analyst Ratings

BenzingaAug 9 12:43 ET

Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target

BenzingaAug 9 12:42 ET

Emergent BioSolutions Analyst Ratings

BenzingaJul 2 10:46 ET

Emergent BioSolutions Analyst Ratings

BenzingaJun 24 11:12 ET

Emergent BioSolutions Analyst Ratings

BenzingaJun 20 07:37 ET

Emergent BioSolutions Analyst Ratings

BenzingaApr 11 09:07 ET

Analysts' Top Healthcare Picks: Emergent Biosolutions (EBS), Vera Therapeutics (VERA)

TipRanksApr 11 07:25 ET

Emergent BioSolutions Analyst Ratings

BenzingaMar 7 10:41 ET

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and Emergent Biosolutions (EBS)

TipRanksJan 11 10:20 ET

Emergent BioSolutions Analyst Ratings

BenzingaNov 20, 2023 08:27 ET

Emergent BioSolutions Analyst Ratings

BenzingaAug 29, 2023 06:38 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (ALNY), Galapagos (GLPG) and Emergent Biosolutions (EBS)

TipRanksMay 31, 2023 12:30 ET

What 4 Analyst Ratings Have To Say About Emergent BioSolutions

BenzingaMay 31, 2023 12:01 ET